The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure.
A global team of researchers has reported a groundbreaking discovery in cardiac regeneration that offers new hope for the ...
The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure. Researchers in the Michael E. DeBakey Department of Surgery at ...
9don MSN
Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure.
A discovery in cardiac regeneration offers ew hope for the treatment of ischemic heart failure. Published in npj Regenerative ...
Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...
Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions report a ...
3don MSN
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...
12d
GlobalData on MSNGenentech wins FDA approval for second stroke treatmentGenentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.
A study has found that in patients with ischemic heart disease receiving ventricular tachycardia ablation there is higher risk of mortality.
5d
MedPage Today on MSNStress and Strokes; Gene Hackman's CVD Death; PFO Closure for the Nickel-SensitiveAfter transcatheter patent foramen ovale (PFO) closure, patients with nickel hypersensitivity were more likely to develop ...
Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results